吡咯喹啉醌通过调控pmk-1/p38 MAPK通路缓解秀丽线虫缺氧损伤OA
Pyrroloquinoline quinone alleviates hypoxia injury in Caenorhabditis elegans via regulating the pmk-1/p38 mapk pathway
高原低氧会引发剧烈的氧化应激反应,这也是急性高原病、高原肺水肿及细胞功能损伤发生的核心诱因,目前临床上仍缺乏有效的干预手段.吡咯喹啉醌(PQQ)是一种天然存在的邻醌类氧化还原辅因子,具备极强的自由基清除能力与金属螯合作用,能够提升机体的低氧耐受能力.但其具体分子作用机制,尤其是对保守应激信号通路的调控作用,尚未被全面阐明.本研究以秀丽隐杆线虫为模型,探究 PQQ 对低氧所致氧化损伤的细胞保护效应及作用靶点.实验采用野生型线虫(N2 Bristol 品系)与多种突变株线虫(pmk-1(km25)、sek-1(km4)、daf-16(mu86)),利用浓度为 2.0 g/L 的亚硫酸钠构建稳定低氧模型,体系内溶解氧含量低于 0.1 mg/L.实验检测了线虫存活率、形态特征、运动能力等表型指标,同时测定活性氧、脂褐素水平;结合转录组测序(RNA-seq)与基因验证实验,筛选关键信号通路.结果发现 PQQ 的保护作用呈浓度依赖性,其中 1 mmol/L 为最佳作用浓度.低氧对照组线虫存活率仅为 19.9±2.4%,经该浓度 PQQ 处理后,存活率提升至 73.2±4.2%(p<0.001).PQQ 可改善低氧造成的形态异常,将线虫运动能力恢复至常氧状态的 80%~90%;同时使体内活性氧含量下降54.96%,脂褐素含量下降 31.29%,两项指标差异均具有极显著统计学意义(p<0.001).转录组测序结果表明,低氧环境可造成 849 个基因表达发生改变,其中 740 个基因上调、109 个基因下调,差异基因主要富集于氧化磷酸化、脂肪酸代谢及钙信号通路.而 PQQ 可逆转上述基因表达变化,对钙稳态相关基因与丝裂原活化蛋白激酶(MAPK)通路基因的下调作用尤为突出.进一步通过基因功能验证实验发现,在 daf-16(mu86)突变株中,PQQ 的保护效果出现部分减弱;而在 pmk-1(km25)与 sek-1(km4)突变株中,PQQ 的保护效应完全消失.综上所述,PQQ 可通过维持钙稳态、抑制促凋亡的 pmk-1/p38 MAPK 通路,并部分依托胰岛素/胰岛素样生长因子信号通路,缓解秀丽隐杆线虫因低氧诱导产生的氧化应激.本研究揭示了 PQQ 抗氧化、提升机体适应能力的分子机制,为将其应用于高原低氧相关疾病的防治提供了理论依据.
High-altitude hypoxia induces severe oxidative stress,a key driver of acute mountain sickness(AMS),high-altitude pulmonary edema(HAPE),and cellular dysfunction with limited effective interventions.Pyrroloquinoline quinone(PQQ),a naturally occurring redox-active ortho-quinone cofactor with robust free radical scavenging and metal-chelating properties,enhances hypoxia tolerance,but its molecular mechanisms—especially modulation of conserved stress-signaling cascades—remain incompletely defined.We investigated PQQ's cytoprotective effects and mechanistic targets against hypoxia-induced oxidative injury using Caenorhabditis elegans(C.elegans).Wild-type(N2 Bristol)and mutant(pmk-1(km25),sek-1(km4),daf-16(mu86)worms were exposed to 2.0 g/L sodium sulfite(Na2SO3)to induce stable hypoxia(<0.1 mg/L dissolved oxygen).Phenotypic analyses included survival,morphometry,locomotor activity,and measurements of reactive oxygen species(ROS)and lipofuscin,with transcriptomic profiling(RNA-seq)and genetic validation to identify key signaling pathways.PQQ exerted concentration-dependent protection,with 1 mmol/L as the optimal concentration,increasing survival from 19.9±2.4%(hypoxia control)to 73.2±4.2%(p<0.001).It reversed hypoxia-induced morphological abnormalities,restored locomotor function to 80-90%of normoxic levels,and reduced ROS by 54.96%and lipofuscin by 31.29%(both p<0.001).RNA-seq revealed hypoxia altered 849 genes(740 upregulated,109 downregulated),enriched in oxidative phosphorylation,fatty acid metabolism,and calcium signaling—effects reversed by PQQ,particularly downregulation of calcium homeostasis and mitogen-activated protein kinase(MAPK)pathway genes.Genetic validation showed PQQ's protection was partially attenuated in daf-16(mu86)mutants but completely abrogated in pmk-1(km25)and sek-1(km4)mutants.These findings demonstrate PQQ mitigates hypoxia-induced oxidative stress in C.elegans via maintaining calcium homeostasis,suppressing the pro-apoptotic pmk-1/p38 MAPK pathway,and partially engaging the insulin/insulin-like growth factor signaling(IIS)pathway,providing novel mechanistic insights into PQQ's antioxidant and adaptogenic properties to support its potential therapeutic utility for high-altitude hypoxic pathologies.
张泊宁;冯雪儿;刘缨;卢涛
北京中医药大学 生命科学学院,北京 102488北京中医药大学 生命科学学院,北京 102488北京中医药大学 生命科学学院,北京 102488北京中医药大学 生命科学学院,北京 102488
生物科学
吡咯喹啉醌(PQQ)低氧氧化应激秀丽隐杆线虫钙信号p38 MAPK通路
Pyrroloquinoline quinone(PQQ)HypoxiaOxidative stressCaenorhabditis elegansCalcium signalingp38 MAPK pathway
《生物信息学》 2026 (3)
208-228,21
国家自然科学基金项目(No.U23A20522)LUTAO:"Investigation on the Mechanism of Action and Clinical Efficacy Observation of PQQ and Its Compound Formulations in Alzheimer's Disease,Age Reversal,and Anti-Aging Related Diseases"(No.90020371720023).
评论